overall-survival

Documents about overall-survival

• Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study#160313ClinicalTrials.gov
• PFS and OS of Patients With Advanced Neuroendocrine Cancer (NEN) After Systemic Treatment#979914ClinicalTrials.gov
• A Non-interventional Retrospective Study on Overall Survival in Completely Resected Chinese NSCLC Patients With Adenocarcinoma Histology- ICAN Extension Study#1010879ClinicalTrials.gov
• Prognostic Values of Hemoglobin and Red Blood Cell Distribution Width to Overall Survival in Non-Hodgkin Lymphoma#930445Acta Interna: The Journal of Internal Medicine
• Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer#873434ClinicalTrials.gov
• DataBase for Analysis of Rectal Cancer Oncological Results#307432ClinicalTrials.gov
• Determination of Immune Phenotype in Glioblastoma Patients#833548ClinicalTrials.gov
• The impact of starting dose on overall survival in myelofibrosis patients treated with ruxolitinib: A prospective real-world study on AIFA monitoring registries#185485IRIS
• Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer#848437ClinicalTrials.gov
• Mesenteric Lymph Node Metastasis and Nutritional Status After Bowel Resection for Ovarian Cancer#839444ClinicalTrials.gov
• Jejunoileal vs Gastric GIST in the Era of Imatinib.#857898ClinicalTrials.gov
• Surgical Outcome and Predictors of Overall Survival of Stage I-III Appendiceal Adenocarcinoma#902132ClinicalTrials.gov
• Baseline D-dimer as a predictor of immune checkpoint inhibitor efficacy in cancer#4693Europe PMC
• Endostar Combined With AI Regimen Compared With AI in Adjuvant Treatment#851802ClinicalTrials.gov
• Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer#432859ClinicalTrials.gov
• The Overall Survival of Patients With Unresectable HCC in Real-life#878835ClinicalTrials.gov
• A Single-center, Single-arm Clinical Study Evaluating the Short-term Efficacy of Inflatable Mediastinoscopic-assisted Transhiatal Laparoscopic Esophagectomy for the Radical Resection of Thoracic Esophageal Cancer#864468ClinicalTrials.gov
• Machine-Learning-Based Survival Prediction in Glioblastoma Using Graph-Theoretical Analysis of Structural Network Alterations#120134Europe PMC
• The Value of Geriatric Assessments in Older Patients With Breast Cancer#894947ClinicalTrials.gov
• Impact of the French ENDOCAN–COMETE Network on Overall Survival in Rare Adrenocortical Carcinomas#213139HAL (France)
• Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapy#465508PubMed Central
• Exercise and Mortality in Middle-Aged and Older Adults#897645ClinicalTrials.gov
• The Clinical Research of Neoadjuvant Chemotherapy Combined Surgery for Locally Advanced Cervical Cancer#852788ClinicalTrials.gov
• Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics#881009ClinicalTrials.gov
• Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma#856337ClinicalTrials.gov
• Survival Prediction in Patients With Bladder Cancer Undergoing Radical Cystectomy Using a Machine Learning Algorithm: Retrospective Single-Center Study#26266HAL (France)
• International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma#872547ClinicalTrials.gov
• Statin Combination Therapy in Patients Receiving Sorafenib for Advanced Hepatocellular Carcinoma#831570ClinicalTrials.gov
• Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma#208453ClinicalTrials.gov
• Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients#810571ClinicalTrials.gov
• Predictive Factors of Survival With and Without Repetition With 5 and 10 Years Curative Post-oesophagectomy for Cancer of the Oesophagus#862806ClinicalTrials.gov
• Decision Tree Model for Predicting the Overall Survival of Endometrial Cancer Patients with Adenomyosis.#458602NCBI PubMed Central
• Incidence, Risk Factor, Treatment and Overall Survival of Locally Recurrent Rectal Cancer#801490ClinicalTrials.gov
• Relationship between overall survival and progression-free survival with 18 F-FDG PET/CT metabolic parameters in metastatic breast cancer patients treated with CDK 4/6 inhibitors#310720AVESIS
• Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival#875076ClinicalTrials.gov
• Predictive value of EGFR amplification and EGFRvIII mutation in EGFR-targeted therapy for recurrent glioblastoma: a systematic review#304159Europe PMC
• Lymphovascular space invasion as a prognostic factor of epithelial ovarian cancer: a multicenter study by the FRANCOGYN group#350758HAL (France)
• Initial treatment patterns and survival in biliary tract cancer: A retrospective cohort study in Kyoto, Japan#665374HAL (France)
• Meta-Analysis of Overall Survival in Intramedullary Spinal Gliomas: Comparing Gross Total Resection to Subtotal Resection and Biopsy#28624bioRxiv / medRxiv
• Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC#326310HAL (France)
• Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials: A Meta-Epidemiological Analysis.#247837NCBI PubMed Central
• Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC#841792ClinicalTrials.gov
• A Study of Overall Survival in Participants With Metastatic Colorectal Cancer (mCRC)#885117ClinicalTrials.gov
• Study of Cetuximab to Treat Gastric Cancer#887131ClinicalTrials.gov
• A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy#981963ClinicalTrials.gov
• A nomogram based on systemic inflammatory markers: development and validation for predicting postoperative overall survival in gastric cancer.#368066NCBI PubMed Central
• Surveillance AFter Extremity Tumor surgerY#835515ClinicalTrials.gov
• Midostaurin Associated With Standard Chemotherapy in Patients With Core-binding Factor Leukemia#848735ClinicalTrials.gov
• Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma#978953ClinicalTrials.gov
• Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer#873405ClinicalTrials.gov